Company Quick10K Filing
Gilla
10-Q 2018-06-30 Filed 2018-09-28
10-Q 2018-03-31 Filed 2018-06-29
10-K 2017-12-31 Filed 2018-05-03
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-31
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-04-08
10-Q 2015-09-30 Filed 2015-11-20
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-03-31
10-Q 2014-09-30 Filed 2014-11-18
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-21
10-K 2013-12-31 Filed 2014-04-08
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-04-01
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-15
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-11
10-K 2010-12-31 Filed 2011-04-15
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-08-16
10-Q 2010-03-31 Filed 2010-05-17
10-K 2009-12-31 Filed 2010-03-31
8-K 2018-06-22
8-K 2018-05-17
8-K 2018-03-08

Gilla Financials

GLLA Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Cardax (CDXI) 13,726 42% -4.3 -173% 2,114 8,379 440 185 -3,651 -3,366 14,534
Enzon Pharmaceuticals (ENZN) 13,707 0% 2.9 -6% 12,070 5,753 158 0 -717 1,283 3,691
Applied Biosciences (APPB) 13,547 40% -4.8 -99% 3,484 1,323 1,103 444 -3,443 -2,807 13,474
Rare Element Resources (REE) 13,531 -11.1 -63% 1,798 1,757 0 0 -1,125 -1,125 12,461
Vitaxel Group (VXEL) 13,522 12% -45.6 -110% 268 4,708 60 7 -295 -295 13,467
ALR Technologies (ALRT) 13,439 -4.0 -1,000,714% 1 30,357 0 0 -5,964 -3,374 13,438
RMG Networks Holding (RMGN) 13,388 55% -2.7 -40% 19,219 18,489 35,066 19,291 -7,733 -4,380 11,651
Nanophase Technologies (NANX) 13,348 23% -7.5 -22% 9,139 7,906 10,118 2,279 -2,022 -1,648 12,386
TSS (TSSI) 13,331 37% 25.0 -2% 11,879 9,471 12,375 4,585 -220 376 9,387
Kiwa Bio-Tech (KWBT) 13,189 25% 175.6 -5% 33,145 19,558 31,454 7,926 -1,544 77 13,521
XSport Global (TLLT) 13,108 39% -7.7 -312% 774 4,664 1,814 714 -2,418 -1,805 13,877
Strategic Environmental & Energy Resources (SENR) 13,073 0% -11.6 -65% 3,038 8,740 4,192 0 -1,982 -1,154 13,379
Gilla (GLLA) 12,944 65% -3.1 -134% 4,303 12,570 4,388 2,873 -5,761 -4,419 13,882
Parks America (PRKA) 12,720 0% 5.1 10% 10,763 1,839 6,184 0 1,097 2,025 10,303
Black Box (BBOX) 12,647 27% 57.9 -21% 297,764 237,819 738,286 202,895 -63,375 1,605 92,921
Inrad Optics (INRD) 12,499 19% -24.7 -9% 7,130 5,043 7,444 1,445 -671 -474 11,687
HealthLynked (HLYK) 12,431 62% -4.3 -115% 2,661 5,067 2,846 1,772 -3,066 -2,841 12,328
CannaPowder (CAPD) 12,403 -5.6 -2,548% 86 0 0 0 -2,194 -2,194 12,334
Rangeford Resources (RGFR) 12,303 -16.3 -156,832% 1 2,524 0 0 -801 -801 13,102
Curaegis Technologies (CRGS) 12,193 15% -8.8 -1,243% 284 11,804 13 2 -3,530 -2,550 22,368

Balance Sheet ($'000)2012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-30
Cash117121035642604971251598234681853163147662442
Accounts Receivable011236373331554649542380344168281232211174
Inventory1791119152797776147155195351545576556404451527601
PP&E44456111166612519921822614795151417407401414
Assets1630513125297398291,0864857611,5562,2312,6772,6212,4232,8482,6124,7004,2814,3794,303
Accounts Payable8096841101253874943094033546186881,2241,5701,7581,7531,5931,9562,1882,6333,012
Long-Term Debt22500753763779767783865547845802981
Liabilities8181,0981,4331,9671,7532,1832,5682,6402,5233,0774,2485,0016,1736,8688,1147,8407,67810,17510,83611,74112,570
Stockholders' Equity-802-1,069-1,382-1,655-1,225-1,444-1,739-1,553-2,038-2,317-2,692-2,770-3,496-4,247-5,691-4,992-5,066-5,475-6,555-7,363-8,268
Income Statement ($'000)2012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-30
Revenue0028491914448173391,3579121,2441,2661,0761,0151,2661,031
Cost of Revenue233832620560346861345547494452148529309
Gross Profit511-13824256-7496567697772624867737645
R&D
SG&A2591212322144015193662405098691,0471,7529971,1471,0461,7131,4531,431
Tax000000000000000000
Net Income-278-339-413-472-664-599-670-418-698-1,265-906-1,492-898-2,633-981-2,136-1,461-1,183
Cash Flow ($'000)2012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-30
Cash Operating-111-188-246-254-658101-227-79-228-357-738-581-917-333-283-365-442-395
Cash Investing-200-1-45-20-3600-225-25-43-18-120-6210-1-19
Cash Financing121162477433343-26-3093621913887156621,109378145388317407